Comparing Voiding Trials After Midurethral Sling for Stress Incontinence
Stress Urinary Incontinence, Urethral Hypermobility, Cystocele
About this trial
This is an interventional treatment trial for Stress Urinary Incontinence focused on measuring midurethral sling, Voiding trial, stress urinary incontinence
Eligibility Criteria
Inclusion Criteria:
- Postoperative patients after placement of midurethral sling (retropubic sling or transobturator) with or without anterior or posterior colporrhaphy.
- Ability to provide informed consent and complete all study requirements
Exclusion Criteria:
- Patients who underwent a surgery that requires long term catheterization (i.e fistula repair or urethral diverticulum)
- Patients who sustained a cystotomy during surgery as our divisional protocol is to send these patients home with a Foley catheter for 5-14 days without a voiding trial
- Patients who had an apical repair for pelvic organ prolapse (Uterosacral vaginal vault suspension, Abdominal sacral colpopexy, sacrospinous ligament fixation)
Sites / Locations
- Urogynecology, Female Pelvic Medicine and Reconstructive Surgery
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
FAST voiding trial method
Retrograde fill voiding trial method
1) Bladder drained with indwelling foley catheter, then retrograde filled with 300cc sterile water. 2) catheter is removed; 3) Patient voids within 20 minutes (if unable to void after 20 minutes, she will be discharged home with a catheter secondary to voiding dysfunction). 4) The patient will subjectively quantify their FOS via VAS scale. 5) If VAS scale >50 (=50%) the catheter will remain out, patient is discharged home without measuring a PVR 6) If VAS scale is from 0-49 (= 0-49%) a PVR will be checked via bladder scan. If PVR is <500 the patient will be discharged WITHOUT a catheter; If PVR is >500 the patient will be discharged WITH a catheter. If she is discharged with an indwelling foley catheter, she will have an in-office retrograde voiding trial in 2-5 days
1) Bladder drained with indwelling foley catheter, then retrograde filled with 300cc sterile water. 2) catheter is removed; 3) Patient voids within 20 minutes (if unable to void after 20 minutes, she will be discharged home with a catheter secondary to voiding dysfunction). 4) The patient will subjectively quantify their FOS via VAS scale (however this information will only be used for research purposes). 5) If she voids >/= 2/3 (200cc) the catheter will remain out as she will have passed her voiding trial. If she voids < 200cc she will be discharged home with a catheter and instructed to follow-up in 2-5 days for an in-office retrograde voiding trial in 2-5 days.